Table of Contents

Publications and projects

Peer-Reviewed Articles

Ye, Wenjing et al. Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak. Frontiers in public health (2023).

Li, Kangguo et al. Viral dynamics of omicron BA.2.76 variant of SARS-CoV-2 in a cohort of COVID-19 patients. The Journal of infection (2023).

Li, Kangguo et al. Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China. The Journal of infection (2023).

Li, Kangguo et al. Feasibility of Booster Vaccination in High-Risk Populations for Controlling Coronavirus Variants - China, 2021. China CDC weekly (2021).

Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic. Principle accept by Nature Communications.

Manuscripts in Preprint or Under Review

Pertussis resurgence in Australia, China, the United Kingdom and the United States. Under reviewed by Nature Communications.

Achievements

Academic Standout of Xiangan Campus, Xiamen University (2023), Yanan Scholarship, Xiamen University (2023), National Scholarship of China (2022), Saifu Medical & Pharmaceutical Scholarship (2022) and Excellent Merit Student of Xiamen University (2022)

Epidemiologist Toolbox

Risk Calculator

Reproduction Number Calculator

Epicurve Helper

Geocoding Helper

Map Helper

Time sorting Helper

ggplot2 Helper

Distribution Fitting Helper

CNIDS

Dynamic surveillance

AI-driven Report

Chinese Notifiable Infectious Diseases Surveillance Report

What’s more?

SMTP

provided by gmail to send information (developing)

Forms

provided by microsoft to recording subscribe and unsubscribe

Project design

Further direction

Professionalization

Local deploying open source model to avoid data breaches

Source: Cascella et al. J Med Syst 2024

Internationalization

Including more countries and regions

Source: Healthmap

Pertussis resurgence

Global situation

the UK, the US, Australia, Philippines, European Union and …

(a-b) Australia; (c-d) China; (e-f) the UK; (g-h) the US.

(a-b) Australia; (c-d) China; (e-f) the UK; (g-h) the US.

Possible reasons

Interruptions to routine immunization

The coverage of the third dose of the diphtheria-tetanus-pertussis (DTP3) vaccine from 86% in 2019 to 81% in 2021, the lowest since 2008

PHSMs lead to a lack of immune stimulation in the population

As PHSMs relax, more susceptible individuals may result in pertussis levels approaching or even surpassing pre-pandemic levels

Macrolide-resistant strains of Bordetella pertussis

In 2020, a new type of macrolide-resistant pertussis bacterium containing the pxxP3 and prn2 genes emerged in Shanghai, China, and rapidly spread in the subsequent period, replacing the previous predominant strain.

Acellular pertussis vaccines

limited efficacy in against infection and transmission

National vaccine strategy

More information